Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic dysfunction-associated steatohepatitis (MASH) ...

With GLP-1 shortage officially over, patients who relied on compounded copies have only bad options to choose from ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

India faces a growing liver disease crisis linked to obesity and diabetes, affecting even non-drinkers. Experts warn that ...

A study published in Nature Aging has revealed a promising new drug candidate that may help combat metabolic ...

Eli Lilly announced clinical trial results this week for a daily pill to treat obesity and diabetes. Its name is absolutely ...

The benefit of GLP-1 therapy couldn’t be explained by weight loss, suggesting that some pleiotropic effects may be at work.

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...